Novartis · 1 day ago
Executive Director, Access & Reimbursement
Novartis Pharmaceuticals Corporation is seeking an Executive Director for Access & Reimbursement, a remote-based role that serves as a national leader for aligned field teams. The ED is responsible for co-creating execution strategies and ensuring the delivery of high business impact while fostering a supportive team environment.
BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Attract, coach and retain team of high performing Regional Directors and Access & Reimbursement professionals
Oversee the recruiting, interviewing, hiring, training, and staffing of the management and extended team
Provide frequent, ongoing performance feedback to all direct reports and foster a team-oriented, supportive working environment
Effectively translate pre-specified national strategy to a regional level to enable appropriate exquisite execution and pull through within you team. Motivate each region to align on national strategy and key business impact metrics
Continuously monitor field team operations and seek to identify opportunities to improve efficiencies and effectiveness at a regional and national level
Partner closely with Customer Engagement Team to ensure strong collaboration and coordination of field associate activities, business plans, and customer resolutions
Integrate with Novartis leadership and collaborate across multi-functional teams (Sales, Marketing, Managed Markets, Operations, Training, Legal, Compliance, etc.) to ensure collaborative and compliant approach to support field success
Understand specifics of, and resolve questions associated with, practice and/or patient reimbursement to support on any issues with third party payers
Identify opportunities to complement NPC capabilities to strengthen the ability for patients to have access to therapy
Collaborate with NPS Analytics to design reports and tools to monitor and achieve pre-specified business objective and aligned impact metrics
Qualification
Required
Minimum of 10 years in reimbursement, contract strategy (if applicable), managed care, sales/marketing or related field
Minimum 5 years leading a regional or local team and managing and collaborating across multiple stakeholders
Experience working with highly complex practices and/or health systems to establish access and acquisition pathways
Strategic account management experience using a proactive approach to anticipate access hurdles impacting accounts and patient access
Deep expertise and experience integrating manufacturer-sponsored patient support programs
General knowledge of reimbursement pathways (specialty pharmacy, buy-and-bill, retail)
Experience with specialty products acquired through specialty pharmacy networks and through buy-and-bill process, including expertise in acquisition, billing and coding, claims processing, and reimbursement
Possess a strong understanding of Commercial payers, Medicare plans and state Medicaid in geographic region
Past success in execution of launch strategies and plans
Minimum of a bachelor's degree
Preferred
Advanced degree preferred (Majors preferred: Sciences, Business, Pharmacy, and Healthcare)
Benefits
Health, life and disability benefits
401(k) with company contribution and match
Generous time off package including vacation, personal days, holidays and other leaves
Company
Novartis
Novartis is a pharmaceutical company that researches and develops medicines for serious diseases to improve and extend people's lives.
H1B Sponsorship
Novartis has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (14)
2024 (27)
2023 (23)
2022 (27)
2021 (31)
2020 (25)
Funding
Current Stage
Public CompanyTotal Funding
$2.49BKey Investors
Bill & Melinda Gates Foundation
2024-06-19Post Ipo Debt· $2.49B
2018-02-14Grant· $6.5M
2000-05-19IPO
Leadership Team
Recent News
2026-01-08
2026-01-08
Company data provided by crunchbase